Cancer Biology and Oncology
A section of Biomedicines (ISSN 2227-9059).
Section Information
Scope
This section publishes reviews and original peer-reviewed papers of a high scientific standard, covering all the aspects of innovative cancer therapies. Papers aim to uncover novel therapeutic approaches toward overcoming conventional anticancer drug resistance, a better understanding of the interrelations between cancer and metabolism as well as tumor and microenvironment, along with the discovery of novel diagnostic and prognostic makers. Topics include but are not limited to in vitro and in vivo cancer therapeutic responses, targeted therapies (including metabolism and immunotherapy, such involving CAR-T cells), identification of novel therapeutic targets, and evaluation of novel diagnosis and prognosis markers and the assessment of their impact on morphological, phenotypical, and molecular classifications.
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- The Role of NK Cells in Cancer Immunotherapy: Mechanisms, Evasion Strategies, and Therapeutic Advances (Deadline: 31 May 2026)
- Advances in Liver Oncology: Molecular Mechanisms and Therapeutic Innovations (Deadline: 31 May 2026)
- Past, Present and Further Looking for Therapeutic Management of Pancreatic Ductal Adenocarcinoma (2nd Edition) (Deadline: 31 May 2026)
- Tumor Biomarkers in Gynecology—2nd Edition (Deadline: 31 May 2026)
- Advances in Therapeutic Strategies and Precision Medicine in Solid Tumors and Metastasis—2nd Edition (Deadline: 31 May 2026)
- Immunotherapy and Targeted Treatment in Solid Tumors: Biomarkers and Novel Therapeutic Strategies (Deadline: 31 May 2026)
- Advanced Cancer Diagnosis and Treatment: Third Edition (Deadline: 31 May 2026)
- State-of-the-Art Endocrine Cancer Biology and Oncology (Deadline: 31 May 2026)
- Prostate Cancer Targeted Therapy: Highlighting Advances in Precision Medicine and Rational Combination Approaches (Deadline: 30 June 2026)
- Advances in Brain Tumor Diagnosis: Innovations and Emerging Technologies (Deadline: 30 June 2026)
- New Advances in Ovarian Cancer (Deadline: 30 June 2026)
- Glioma Therapy: Current Status and Future Prospects (Deadline: 30 June 2026)
- Cancer-Associated Thrombosis: From Biomarkers to Diagnostic and Therapeutic Strategies to Optimize Treatment (Deadline: 30 June 2026)
- An Update on Mechanisms and Treatments for Thyroid Cancer in Current Oncology, 2nd Edition (Deadline: 30 June 2026)
- Two Decades of Advances in Colorectal Cancer Prevention and Treatment: From Aspirin to Precision Oncology (Deadline: 30 June 2026)
- New Insights in Radiotherapy: Bridging Radiobiology and Oncology (Deadline: 30 June 2026)
- Therapeutic Resistance in Oral Cancer: Mechanisms, Biomarkers, and Novel Strategies to Restore Treatment Responses (Deadline: 30 June 2026)
- New Insights in Hematologic Malignancies: From Pathophysiologic Mechanisms to Therapeutic Strategies (Deadline: 30 June 2026)
- Advances in the Pathogenesis and Treatment of Acute Myeloid Leukemia—2nd Edition (Deadline: 30 June 2026)
- Urogenital Cancers: New Molecular and Translational Aspects on Carcinogenesis and Treatments (2nd Edition) (Deadline: 30 June 2026)
- Advances of Microbiome in Human Cancers (Deadline: 30 June 2026)
- Advances in Precision Oncology for Thyroid Carcinoma: Integrating Artificial Intelligence, Genomics and Molecular Diagnostics (Deadline: 30 June 2026)
- Oral Squamous Cell Carcinoma: Molecular Signaling Pathways and Novel Biomarkers—2nd Edition (Deadline: 30 June 2026)
- Tumour Angiogenesis and Anti-Angiogenic Therapy (Deadline: 30 June 2026)
- Breast Cancer: Molecular and Translational Aspects on Carcinogenesis and Treatments (Deadline: 30 June 2026)
- Precision Oncology in Solid Tumors: Emerging Biomarkers and Therapeutic Targets (Deadline: 30 June 2026)
- Update on Cancer Therapy (Deadline: 30 June 2026)
- Genomics and Epitranscriptomics Regulation in Cancer (Deadline: 30 June 2026)
- Advanced Research in Hematological Malignancies (Deadline: 30 June 2026)
- AI/Machine Learning-Driven Multi-Omics Research in Oncology (Deadline: 30 June 2026)
- Bowel Cancer: From Early Diagnosis to Personalized Treatment Strategies (Deadline: 30 June 2026)
- Advanced Research in Melanoma Metastasis (Deadline: 30 June 2026)
- Advances in the Diagnosis and Treatment of Urothelial Cancers (Deadline: 30 June 2026)
- Genitourinary Cancers: From Molecular Pathogenesis to Precision Diagnosis and Therapy (Deadline: 30 June 2026)
- Neurological Complications in Oncology: From Pathogenesis to Therapy (Deadline: 30 June 2026)
- Metabolic Reprogramming and Immune Modulation in the Tumor Microenvironment: From Mechanisms to Immunotherapy Enhancement (Deadline: 30 June 2026)
- Novel Strategies for Oncogene-Addicted Lung Cancers: Not Rare Anymore (Deadline: 31 July 2026)
- Advancements and Challenges in Anticancer Targeted Therapy with Small Molecules (Deadline: 31 July 2026)
- Strategies for Anticancer in p53 Mutated Cancers (Deadline: 31 July 2026)
- Clinical Advances in Hepatocellular Carcinoma (Deadline: 31 July 2026)
- Current Perspectives on Gynecologic Cancers (Deadline: 31 July 2026)
- Breast Cancer Research: Charting Future Directions (Deadline: 31 July 2026)
- Recent Advances in Gastrointestinal Cancers: From Microbiota Modulation to New Therapeutic Approaches—2nd Edition (Deadline: 31 July 2026)
- Dopamine and Androgen Receptor Signaling: Novel Insights in Cancer Biology (Deadline: 31 July 2026)
- Advancing Precision Radiation Oncology in Head and Neck Cancers (Deadline: 31 July 2026)
- Advanced Molecular Diagnosis and Treatment of Biliary Cancer (Deadline: 31 July 2026)
- Molecular Diagnosis and Genomic Insights in Cancer (Deadline: 31 July 2026)
- Esophageal Cancer: Pathogenesis and Therapeutic Strategies (Deadline: 31 July 2026)
- Advances in Radiological and Optical Imaging for Clinical Oncology (Deadline: 31 July 2026)
- Modern Approaches to Breast Cancer Biology and Therapy (Deadline: 31 July 2026)
- The Development of Cancer Immunotherapy (2nd Edition) (Deadline: 31 July 2026)
- Macrophages and Immune Modulation in Cancer Therapy (Deadline: 31 July 2026)
- Multidisciplinary Advances in Cancer Care—Innovations in Early Detection, Precision Medicine, and AI Driven Strategies (Deadline: 31 July 2026)
- Bridging Advanced Research and Clinical Applications: AI and Molecular Insights in Gynecologic Oncology (Deadline: 31 July 2026)
- State-of-the-Art Cancer Biology, Biodiagnostics and Therapeutics in Japan—Second Edition (Deadline: 31 July 2026)
- Tumor Microenvironment in Cancer: Basic Science, Artificial Intelligence, and Clinical Research (Deadline: 31 August 2026)
- Epigenetics in Human Cancer: Emerging Biomarkers and Therapeutic Targets (Deadline: 31 August 2026)
- MASH and Hepatocellular Carcinoma (HCC)—2nd Edition (Deadline: 31 August 2026)
- Advancements in Research on Pancreatic Cancer: From Biomarkers to Targeted Therapies (Deadline: 31 August 2026)
- Tumor Microenvironment in Head and Neck Squamous Cell Carcinoma (Deadline: 31 August 2026)
- Drug Resistance and Novel Targets for Cancer Therapy—Third Edition (Deadline: 31 August 2026)
- Emerging Trends in Head and Neck Squamous Cell Carcinoma (Deadline: 31 August 2026)
- Tumor Immune Microenvironment and Immune Escape Mechanisms in Cancer Progression and Therapy (Deadline: 31 August 2026)
- EGFR-Mutant NSCLC: Novel Strategies for Resistant and Atypical Subsets (Deadline: 31 August 2026)
- Brain Tumors: From Pathophysiology to Novel Diagnostic and Therapeutic Approaches (Deadline: 31 August 2026)
- CAR T-Cell Therapy in Solid Tumors (Deadline: 31 August 2026)
- Biomarkers and Therapeutic Targets in Gastric Cancer: From Basic Research to Clinical Applications (Deadline: 11 September 2026)
- Prostate Cancer Pathology: Recent Advances and Future Perspectives (Deadline: 15 September 2026)
- Emerging Trends in Cancer: Biomarkers, Therapeutic Strategies and Future Directions (Deadline: 25 September 2026)
- Emerging Trends in Malignant Mesothelioma (Deadline: 30 September 2026)
- Epigenetics and Immune Perspectives in Cancer: Overcoming Therapy Resistance (Deadline: 30 September 2026)
- Genetic Insights and Pharmacogenomic Approaches in Cancer Treatment (Deadline: 30 September 2026)
- Matrix Biology Insights: Unraveling the Role of Proteinases, Fibroblasts, and Extracellular Matrix Metalloproteinase Inducer in the Tumor Microenvironment (Deadline: 30 September 2026)
- New Treatments for Colorectal Cancer (Deadline: 30 September 2026)
- Advances in Cancer Metastasis Modeling: From Mechanisms to Therapies (Deadline: 30 September 2026)
- The Tumor Microenvironment and Heterogeneity: Challenges and Opportunities in Multiple Myeloma Immunotherapy (Deadline: 30 September 2026)
- Advanced Research in Cancer Immunotherapy (Deadline: 30 September 2026)
- New Insights into Breast Cancer Management: From Tumorigenesis to Personalized Treatments—2nd Edition (Deadline: 30 September 2026)
- Advancements in the Treatment of Colorectal Cancer (Deadline: 30 September 2026)
- Advances and Challenges in the Treatment of Pediatric Chronic Myeloid Leukemia (Deadline: 30 September 2026)
- Advancements in Artificial Intelligence (AI) for Cancer Genomics and Genetics—2nd Edition (Deadline: 30 September 2026)
- Novel Biomarkers and Liquid Biopsy in Gastrointestinal Cancer (Deadline: 30 September 2026)
- Gene Therapies in Ovarian Cancer (Deadline: 30 September 2026)
- Head and Neck Cancer: From Mechanisms to Therapeutic Approaches—Advances and Challenges (Deadline: 31 October 2026)
- Lymphomas: From Mechanisms to Therapeutic Approaches (Deadline: 31 October 2026)
- Advances in Cancer Treatment (Deadline: 31 October 2026)
- Emerging Technologies in Liquid Biopsy of Cancers (Deadline: 31 October 2026)
- Advances in Single-Cell and Spatial Transcriptomics: Decoding Tumor Heterogeneity and Microenvironment (Deadline: 31 October 2026)
- New Insights into the Diagnosis and Treatment of Hepatocellular Carcinoma—2nd Edition (Deadline: 31 October 2026)
- Decoding Resistance: Molecular Drivers of Therapy Failure in Advanced Prostate Cancer (Deadline: 31 October 2026)
- Novel Biomarkers and Precision Medicine in Gynecologic Malignancies (Deadline: 31 October 2026)
- Pancreatic Cancer: From Mechanisms to Therapeutic Approaches (4th Edition) (Deadline: 31 October 2026)
- Molecular Research in Genitourinary Oncology (Deadline: 31 October 2026)
- Advances in Lung Cancer: From Bench to Bedside (2nd Edition) (Deadline: 31 October 2026)
- New Insights into Mechanism of Breast Cancer Development and Resistance to Therapy (Deadline: 31 October 2026)
- Thoracic Malignancies: From Pathophysiology to Novel Therapeutic Approaches: 2nd Edition (Deadline: 31 October 2026)
- Computational and Translational Advances in Precision Oncology (Deadline: 31 October 2026)
- Small Molecule Inhibitors for Cancer Therapy (Deadline: 31 October 2026)
- Advances in Immunotherapy and Radiation Therapy for Cancer (2nd Edition) (Deadline: 30 November 2026)
- Pediatric Tumors: Diagnosis, Pathogenesis, Treatment, and Outcome (Deadline: 30 November 2026)
- Liver Cancer: Molecular and Translational Insights of Carcinogenesis and Treatments (Deadline: 30 November 2026)
- Advances in Natural and Synthetic Anticancer Agents: Mechanistic Insights and Translational Pathways (Deadline: 30 November 2026)
- Advances in Cancer Biology and Experimental Anticancer Therapies (3rd Edition) (Deadline: 30 November 2026)
- Artificial Intelligence in Cancer Imaging: Advancing Precision Oncology (Deadline: 30 November 2026)
- Recent Advances in Diagnosis, Therapeutics, and Mechanistic Research of Multiple Myeloma (Deadline: 30 November 2026)
- Brain Tumor: From Pathophysiology to Novel Therapies (Deadline: 30 November 2026)
- Epigenetic and Post-Translational Regulations of Cancer Cell Fate: Metabolism, Plasticity, and Therapeutics (Deadline: 30 November 2026)
- Glioblastoma: Molecular and Immune Pathology for the Development of Novel Therapies (Deadline: 30 November 2026)
- Mechanisms of Drug Resistance in Cancers (Deadline: 30 November 2026)
- Single-Cell and Multi-Omics in Precision Oncology: From Biomarkers to Therapeutic Targets (Deadline: 30 November 2026)
- Cancer Immunotherapy: Molecular Research and Application (Deadline: 15 December 2026)
- New Advances in Cancer Metabolic Reprogramming: From Molecular Mechanisms to Therapeutic Strategies (Deadline: 30 December 2026)
- Advances in Therapeutic Strategies in Gynecological Malignant Tumors—2nd Edition (Deadline: 31 December 2026)
- Advances in Skin Tumors: From Pathogenesis to Treatment Strategies (Deadline: 31 December 2026)
- Tumor Immune Microenvironment, Metabolic Remodeling and Mechanism of Cancer Metastasis (Deadline: 31 December 2026)
- New Advances in the Treatment of Brain Tumors (Deadline: 31 December 2026)
- Gynecological Cancers: Progress and Challenges (Deadline: 31 December 2026)
- Skin Cancer: From Molecular Mechanisms to Clinical Translation (Deadline: 31 December 2026)
- Biomarkers in Solid Tumors: Recent Advances and Challenges (Deadline: 31 December 2026)
- Urological Oncology: Advances in Precision Diagnosis and Targeted Therapies (Deadline: 31 December 2026)
- Interplay Between Lipid Metabolism and Human Cancers: Molecular Mechanisms and Therapeutic Potential of Natural Products (Deadline: 31 December 2026)
- New Advances in Prostate Cancer (Deadline: 31 December 2026)
- Autophagy–Apoptosis Crosstalk in Cancer: Molecular Pathways and Pathology, Drug Delivery and Resistance, and Therapeutic Innovations (Deadline: 31 December 2026)
- Hepatic Carcinoma: New Advances in Pathogenesis, Diagnosis and Therapy (Deadline: 31 December 2026)
- Genomic Landscapes and Targeted Therapies in Leukemia (Deadline: 31 December 2026)
- Novel Cell Death Mechanism: Pioneering New Avenues in Cancer Therapy (Deadline: 31 December 2026)
- Lung Cancer: Advances in Diagnosis and Treatment (Deadline: 31 December 2026)
- Autophagy-Mediated Signalling in Cancer Metastasis and Progression (Deadline: 10 January 2027)
- Mechanisms and Novel Therapeutic Approaches for Gliomas: 2nd Edition (Deadline: 30 January 2027)
- Innovative Therapeutic Strategies and Molecular Mechanisms in Breast Cancer (Deadline: 31 January 2027)
- Thyroid Cancer: Molecular and Translational Aspects on Carcinogenesis and Treatment (Deadline: 28 February 2027)
- Innovations in Radiation Oncology (Deadline: 31 March 2027)
- Recent Advances in Research on Neuroendocrine Neoplasms and Endocrine Sequelae After Oncological Disease (Deadline: 30 April 2027)
Topical Collection
Following topical collection within this section is currently open for submissions:
